Fremanezumab (TEV-48125)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fremanezumab (TEV-48125), covering 2019-08-28 to 2019-08-28. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine [Phase 3]